Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fluticasone

A synthetic fluorine-containing corticosteroid, patented in 1980 and approved for medical use in 1990: it is inhaled for asthma and COPD and used as a nasal spray for allergic rhinitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?What is swallowed is poorly absorbed and almost entirely broken down by the gut and liver before reaching the circulation: taken by mouth, its bioavailability is below 1%.

FluticasoneGo to the active ingredient →
FluticasoneActive ingredientFluticasoneCat. No. P-F104-001CAS 90566-53-3

EDQM standards 8

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.